Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy

Nanomedicine

Volumn 3, Issue 4, 2008, Pages 453-463

  Murakami, Tatsuya ^a,b   Sawada, Hirohide ^a   Tamura, Goshu ^c   Yudasaka, Masako ^b   Iijima, Sumio ^b,c   Tsuchida, Kunihiro ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b NEC CORPORATION   (Japan)

^c MEIJO UNIVERSITY   (Japan)

Author keywords

Axillary lymph node; Carbon nanohorn; Conjugate; Doxorubicin; Local chemotherapy; Lymphatic delivery; PEGlyation

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG CARRIER; MACROGOL; NANOHORN; WATER;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DISPERSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TISSUE LEVEL; DRUG TRANSPORT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IC 50; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; DRUG CARRIERS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOTUBES, CARBON; NEOPLASMS; WATER; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 56549127420     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/17435889.3.4.453     Document Type: Article

References (33)

1. Muggia FM: Liposomal encapsulated anthracyclines: new therapeutic horizons. Curr. Oncol. Rep. 3, 156-162 (2001).
2. Mizushima Y, Hoshi K: Review: recent advances in lipid microsphere technology for targeting prostaglandin delivery. J. Drug Target. 1, 93-100 (1993).
3. Adler-Moore J, Proffitt RT: AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. J. Antimicrob. Chemother. 49(Suppl. 1), 21-30 (2002).
4. Okada H, Heya T, Ogawa Y, Toguchi H, Shimamoto T: Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate. Pharm. Res. 8, 584-587 (1991).
5. Nishiyama N, Kataoka K: Current state, achievements and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 112, 630-648 (2006).
6. 2S nanocolloids for drug delivery. Mater. Sci. Eng. 23, 113-116 (2003).
7. Iijima S, Yudasaka M, Yamada R et al.: Nano-aggregates of single-walled graphitic carbon nano-horns. Chem. Phys. Lett. 309, 165-170 (1999).
8. Ajima K, Yudasaka M, Suenaga K, Kasuya D, Azami T, Iijima S: Material storage mechanism in porous nanocarbon. Adv. Mater. 16, 397-401 (2004).
9. Miyawaki J, Yudasaka M, Azami T, Kubo Y, Iijima S: Toxicity of single-walled carbon nanohorns. ACS NANO2, 227-234 (2008).
10. Murakami T, Ajima K, Miyawaki J, Yudasaka M, Iijima S, Shiba K: Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro. Mol. Pharm. 1, 399-405 (2004).
11. Ajima K, Yudasaka M, Murakami T, Maigne A, Shiba K, Iijima S: Carbon nanohorns as anticancer drug carriers. Mol. Pharm. 2, 475-480 (2005).
12. Murakami T, Fan J, Yudasaka M, Iijima S, Shiba K: Solubilization of single-wall carbon nanohorns using a PEG-doxorubicin conjugate. Mol. Pharm. 3, 407-414 (2006).
13. Liu Z, Davis C, Cai W, He L, Chen X, Dai H: Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl Acad. Sci. USA 105, 1410-1415 (2008).
14. Isobe H, Tanaka H, Maeda R et al.: Preparation, purification, characterization, and cytotoxicity assessment of water-soluble, transition-metal-free carbon nanotube aggregates. Angew. Chem. Int. Ed. 45, 6676-6680 (2006).
15. Cui D, Tian F, Ozkan CS, Wang M, Gao H: Effect of single wall carbon nanotubes on human HEK293 cells Toxicol. Lett. 155, 73-85 (2005).
16. Wörle-Knirsch JM, Pulskamp K, Krug F: Oops they did again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 6, 1261-1268 (2006).
17. Cherukuri P, Gannon CJ, Leeuw TK et al.: Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc. Natl Acad. Sci. USA 103, 18882-18886 (2006).
18. Lacerda L, Ali-Boucetta H, Herrero MA et al.: Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes. Nanomed. 13, 149-161 (2008).
19. Armstrong DK, Bundy B, Wenzel L et al.: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N. Engl. J. Med.. 354, 34-43 (2006).
20. Hagiwara A, Takahashi T, Kojima O et al.: Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer, Lancet 339, 629-631 (1992).
21. Yan TD, Black D, Sugarbaker PH et al.: A systemic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann. Surg. Oncol. 14, 2702-2713 (2007).
22. Ikehara Y, Niwa T, Biao L et al.: A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res. 66, 8740-8748 (2006)
23. Murata S, Kominsky SL, Vali M et al.: Ductal access for prevention and therapy of mammary tumors. Cancer Res. 66, 638-645 (2006).
24. Fan J, Yudasaka M, Kasuya D et al.: Micrometer-sized graphitic balls produced together with single-wall carbon nanohorns. J. Phys. Chem. B 109, 10756-10759 (2005).
25. Murata K, Kaneko K, Steele WA et al.: Molecular potential structures of heat-treated single-wall carbon nanohorn assemblies. J. Phys. Chem. B 105, 10210-10216 (2001).
26. Veronese FM, Schiavon O, Pasut G et al.: PEG-doxorubicin conjugates influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Bioconjugate Chem. 16, 775-784 (2005).
27. Negishi H, Takeda M, Fujimoto T et al.: Lymphatic mapping and sentine node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol. Oncol. 94, 161-166 (2004).
28. Hagiwara A, Takahashi T, Sawai K et al.: Lymph nodal vital staining with newer carbon particle suspenshions compared with India ink: experimental and clinical observations. Lymphology 25, 84-89 (1992).
29. Stevens A, Lowe J: Human Histology (2nd Edition). Mosby, Times Mirror International Publishers Ltd, London, UK (1997).
30. Gorczyca W, Bigman K, Mittelman A et al.: Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7, 659-670 (1993).
31. Schmied GM, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71, 219-225 (1994).
32. Giuliano AE, Kirgan DM, Michael Guenther J, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 220, 391-401 (1994).
33. Krag D, Weaver D, Ashikaga T et al.: The sentinel node in breast cancer. N. Engl. J. Med. 339, 941-946 (1998).